Abstract
McCance and Widdowson1 have shown that intravenous injection of BAL-Intrav (dithiogiycerol glucoside) increased greatly the urinary excretion of copper in man. In view of the importance of naturally occurring diseases in sheep associated with either a deficiency of copper (for example, enzootic ataxia2 or 'swayback' of lambs) or an excessive storage of copper (for example, toxmic jaundice3), preliminary trials were made to ascertain whether, in sheep, BAL-Intrav would similarly influence the excretion of copper. It was felt that the experimental use of this substance and of related compounds might prove of value in the elucidation of some of the unsolved problems associated with the copper metabolism of the sheep.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
